userPhoto
Position
Vice President, Infectious Diseases & Diagnostics Policy
Company
Biotechnology Innovation Organization (BIO)
Location
Washington District Of Columbia UNITED STATES
Bio
In her role at BIO, Ms. Arthur is responsible for working with member companies in vaccines, molecular diagnostics and bio-defense on policy, legislative and regulatory issues. Ms. Arthur joined BIO in July 2009 as the Director of Healthcare Regulatory Affairs. Prior to joining BIO, she worked in numerous marketing and sales positions for Merck & Co., Inc. in their Vaccine Division. Over her 16 year career in vaccines Ms. Arthur launched several exciting new vaccines in the United States and internationally, including the first HPV vaccine GARDASIL. During her years in Marketing she worked closely with clinical and academic thought leaders in infectious diseases, oncology and public health. In addition, Ms. Arthur also led a large vaccine sales organization of over 75 representatives and managers covering 14 states. Before graduate school, Ms. Arthur worked as a research assistant for two economists at the Brookings Institution in Washington, DC. There she conducted economic analyses related to savings and investment policies for the OECD countries. Ms. Arthur received her B.A. in 1987 in Economics and International Politics from Goucher College and her MBA in 1991 from the Wharton School of Business at the University of Pennsylvania
Agenda
bio2018-mybio-sessionicon-session

9:00 AM–12:00 PM Jun 4, 2018

Room 205ABC, Level 2

Phyllis ArthurVice President, Infectious Diseases & Diagnostics Policy atBiotechnology Innovation Organization (BIO) Timothy BelskiJoint Product Lead for the Advanced Development & Manufacturing Capability atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Lt. Matthew ClarkJoint Product Manager, Chemical Defense Pharmaceuticals atMedical Countermeasure Systems Joseph CohnChief, Research Program Administration Division J9, Research & Development Directorate atDefense Health Agency Jennifer DabischJoint Product Lead for the Diagnostics Product management office atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Syst Dr. Mark DertzbaughCivilian Deputy to the Principal Assistant for Research & Technology atU.S. Army Medical Research and Materiel Command Hannah FeldmanPublic Affairs Specialist atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Tom HandelGeneral Manager and President atMeridian Medical Technologies, Inc. Carl H.Chief Strategic Initiatives Officer atDoD Medical Countermeasure Systems Dr. David HoneChief Scientist, Vaccine and Therapeutic Division, Joint Science and Technology Office atDefense Threat Reduction Agency Nicole KilgoreJoint Product Lead for the Platforms for Rapid Integrated Solutions for Medical Countermeasures atJoint Program Executive Office for Chemical and Biological Defense, Medical Countermeasure Systems Lt. Col. Cindy Landgren, PhDDeputy, Medical Programs atOffice of Deputy Assistant Secretary of Defense, Chemical and Biological Defense Carmen MaherDirector, Medical Regulatory Affairs atJoint Program Executive Office for Chemical and Biological Defense Col. Nelson MichaelDeputy Commander atWalter Reed Army Institute of Research Dr. James PhillipsProjects Officer, Office of the Principal Assistant for Acquisitions atU.S. Army Medical Research and Materiel Command Dr. Jason Roos, PhDDeputy Program Executive Officer atJoint Program Executive Office for Chemical and Biological Defense Dr. Mike StebbinsConsortium Manager atAdvanced Technology International Col. Gary Wheeler, Commander, U.S. Army Medical Research Institute of Infectious Diseases atU.S. Army Medical Research and Materiel Command